Hemolytic Disease of the Newborn

This is a serious condition in newborns caused by a blood group mismatch between the mother and baby. The mother's body makes antibodies that attack the baby's red blood cells, causing anemia and jaundice. It's a type of hemolytic disease of the newborn.

Condition

What people with Hemolytic Disease of the Newborn report

Every report comes from a Lived member, sent anonymously.

Have you tried Light Therapy for Hemolytic Disease of the Newborn?

NameHow it went

About Hemolytic Disease of the Newborn

What It Is

Hemolytic disease of the newborn, also called hemolytic disease of the fetus and newborn (HDFN) or erythroblastosis fetalis, happens when a pregnant woman's immune system makes antibodies against her baby's red blood cells. These antibodies cross the placenta, the organ that links mother and baby, and destroy the baby's red blood cells faster than the baby can replace them. "Hemolytic" means red blood cell breakdown. That breakdown causes two main problems. Before birth, the baby can become anemic, meaning there are too few red blood cells to carry oxygen. Severe anemia can lead to hydrops, a dangerous buildup of fluid in the baby's body, and can be fatal. After birth, the destroyed cells release bilirubin, a yellow substance that causes jaundice (yellowing of the skin and eyes) that appears sooner and is stronger than ordinary newborn jaundice. Severity varies widely: some babies have no symptoms, while others need treatment before they are born.

Causes & Risk Factors

The cause is a mismatch between the mother's and the baby's blood types. Blood types are defined by markers (antigens) on the surface of red blood cells, and a baby can inherit a marker from the father that the mother lacks. Small amounts of the baby's blood can enter the mother's bloodstream, most often during delivery, but also with miscarriage, ectopic pregnancy, abortion, bleeding in pregnancy, amniocentesis, chorionic villus sampling, an injury to the abdomen, or an attempt to turn a breech baby. If her immune system reacts, she becomes sensitized and keeps those antibodies. A transfusion of mismatched blood can sensitize her in the same way. The Rh factor causes the most serious common form. When an Rh-negative mother carries an Rh-positive baby, the first pregnancy is usually not affected, because the antibodies are only starting to form. The risk falls on later Rh-positive pregnancies, and each one can bring a stronger immune response. A mismatch in the main A, B and O blood groups, called ABO incompatibility (most often a mother with type O blood and a baby with type A or B), is the most frequent form but is usually mild. Antibodies to less common markers, such as Kell, are rare but can cause severe disease.

How It's Diagnosed

Testing starts with the mother. At the first prenatal visit, a blood test checks her blood type, her Rh status and an antibody screen, which looks for antibodies against red blood cell markers. A woman who is Rh-negative and has no antibodies may be screened again around 28 weeks. If antibodies are found, the care team identifies which ones they are and measures how much is present, usually repeating the measurement as the pregnancy goes on. They also try to learn whether the baby carries the targeted marker. The father's blood type can help, and for the Rh factor a blood test on the mother can analyze fragments of the baby's DNA that circulate in her blood. If the baby is at risk, a specialist watches for anemia with a Doppler ultrasound of the middle cerebral artery, a blood vessel in the baby's brain. The speed of blood flow there is a reliable noninvasive sign of anemia, which has greatly reduced the need for needle tests. A sample of the baby's blood from the umbilical cord is usually taken only when a transfusion is likely. After birth, the baby's blood is checked for blood type, a complete blood count, a reticulocyte count (immature red blood cells, which show how hard the body is working to replace lost ones), the bilirubin level, and an antiglobulin (Coombs) test that shows whether the mother's antibodies are attached to the baby's red blood cells.

Treatment Options

For the Rh factor, prevention is the most important treatment. Rh immune globulin (such as RhoGAM) is an injection given to an Rh-negative mother who has not already formed antibodies. It is given around 28 weeks of pregnancy, within 72 hours after delivering an Rh-positive baby, and after events such as miscarriage, bleeding, amniocentesis or an abdominal injury. Each dose protects only the pregnancy in which it is given, and it does not help once antibodies have already formed. It also does not prevent ABO or Kell disease. When antibodies are present and the baby becomes severely anemic before birth, the main treatment is an intrauterine transfusion, in which donor red blood cells are given to the baby through the umbilical cord while still in the uterus. Some babies need several transfusions. The procedure is often lifesaving but carries risks, including loss of the pregnancy, and those risks are higher earlier in pregnancy. Delivery is often planned before 37 weeks, weighing further transfusions against the problems of an earlier birth. In very severe cases, treating the mother with intravenous immunoglobulin (IVIG, concentrated donor antibodies) or plasma exchange has been used to try to delay the need for transfusion, but the evidence for these approaches is limited. After birth, treatment depends on how much jaundice and anemia the baby has. Phototherapy uses blue light to change bilirubin into a form the body can clear more easily, and frequent feeding and extra fluids help too. IVIG given to the baby can reduce red blood cell destruction. In severe cases, an exchange transfusion removes much of the baby's blood, along with its bilirubin and antibodies, and replaces it with donor blood. Simple transfusions treat anemia.

What to Expect

The course depends on the type of antibody, how strongly it affects the baby and how early problems begin. Some babies have no symptoms or need only a few days of phototherapy. A pregnancy with significant Rh or Kell disease is managed as high risk, often at a specialized center, with frequent ultrasounds over many weeks. Babies who needed transfusions before birth are often born a little early, commonly around 34 to 36 weeks, and may spend time in a neonatal intensive care unit. The disease does not always end at birth. Red blood cells can keep breaking down for a while, and the baby's own red blood cell production can be slow to recover, so anemia can appear or worsen in the weeks after going home. Some babies need another transfusion after discharge, which is why follow-up blood counts are part of care. Where monitoring and treatment are available, most babies do well, including many who needed transfusions before birth. Studies of children treated with intrauterine transfusion report developmental problems in around 5 percent, with higher risk after severe hydrops, brain injury or early birth. Once a mother has these antibodies, they stay in her body, so later pregnancies with an at-risk baby need monitoring from early on and may be affected more severely.

When to Seek Help

Early in pregnancy, or before it, tell your obstetric care team if you are Rh-negative, have had a baby with this condition, have had a blood transfusion, or have had a miscarriage, abortion or ectopic pregnancy. If you are Rh-negative and have not formed antibodies, contact the care team soon after vaginal bleeding, an injury to the abdomen or a pregnancy loss, because a dose of Rh immune globulin may be recommended. After birth, call the baby's clinician if the skin turns bright yellow, the yellow color reaches the soles of the feet, the jaundice keeps increasing after the first newborn checkup, or it lasts longer than 2 weeks. Keep every scheduled blood count, since anemia can develop after going home. Jaundice together with a fever, a baby who has become listless, or a baby who is not feeding well is an emergency: get the baby seen by emergency care right away.

Questions to Ask Your Doctor

  1. 1.Which antibody do I have, and how likely is it to affect this baby?
  2. 2.How will we monitor the baby for anemia, and what results would lead to treatment?
  3. 3.If a transfusion before birth becomes necessary, where would it be done and what are the risks at this stage of pregnancy?
  4. 4.What blood tests will my baby need after we go home, and for how long?
  5. 5.What does this mean for future pregnancies, and when should monitoring start?

Last reviewed • Oct 2026

Educational content, not medical advice.